Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Funded Symptom Science Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Sorror, Mohamed

Fred Hutchinson Cancer Center
United States

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality 5R01CA227092-06 Marjorie Perloff, M.D.
Sorror, Mohamed

Fred Hutchinson Cancer Center
United States

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality 5R01CA227092-06 Marjorie Perloff, M.D.
Sorror, Mohamed

Fred Hutchinson Cancer Center
United States

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality 5R01CA227092-06 Marjorie Perloff, M.D.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 Rachel Altshuler, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 Rachel Altshuler, Ph.D.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 3UG1CA189821-11S1 Vanessa A. White, M.P.H.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 3UG1CA189821-11S1 Vanessa A. White, M.P.H.
Tamkus, Deimante

Cook County Health And Hospital System
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP 3UG1CA190000-12S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tamkus, Deimante

Cook County Health And Hospital System
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP 3UG1CA190000-12S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Upshaw, Jenica

Beth Israel Deaconess Medical Center
United States

A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S.
Upshaw, Jenica

Beth Israel Deaconess Medical Center
United States

A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S.